References in periodicals archive ?
It is suggested that lympho- proliferative response might be due to specific receptors present on PBLs surface, come in direct contact with Con-A and go through mitotic division.
This research approach will broaden to include other hematological malignancies, including lymphomas, myeloma, lympho- and myelo-proliferative diseases, to also evaluate the metabolic phenotype of these diseases and assess the activity of metabolic targeting molecules.
Syndrome of headache with neurological deficits and CSF lympho- cytosis: a spreading depression mechanism?
Loss of MHC class II gene and protein expression in diffuse large B-cell lympho- ma is related to decreased tumor immu- nosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
4 It is synthesized by a variety of inflammatory cells including endothelial cells megakaryocytes5 granulocytes6 activated lympho- cytes7 and macrophages8 and may be released from these cells following activation.
Table 3: Companies and agencies which have participated in the capstone course recently Company name Title of the project CreatvMicrotech Market analysis for chronic lympho- cytic leukaemia SDNanosciences Market analysis and recommendations for the launch of a new product BioMat Sciences Market analysis of the oral health- care field ProteinOne Identification of potential new products Keygene Marketing strategy GlobalStem Preparation of a five years strategic plan Metamorphix Update of the company's business plan Institute for Advanced Studies Evaluation of a managed care centre in Aging and Geriatric Medicine Towson University Analysis of EST libraries from R.
3 polyendocrinopathy with candidiasis and ectodermal dysplasia (APECED) X-linked lympho- SH2D1A Xq25 proliferative syndrome (SAP) Hyper-IgE syndrome Unknown 4q21 Ectodermal dysplasia IKBKG Xq28 associated with immune (NEMO) deficiency (EDA-ID) Phagocytic defects Congenital neutropenia Unknown Cyclic neutropenia ELASTASE2 19p13.
3% Lympho- vascular Epithelioid Invasion Differentiation 18% 18% Table 3: Showing IHC Profile of ESS (n=11) Case No.